CLINICAL_TRIALS
withdrawal
· 2023-03-17
Clinical Trial Update: Eplerenone as a Supplement to Epidural Steroid Injections [Phase 4]
Summary
A Phase 4 trial evaluating eplerenone as a supplement to epidural steroid injections was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Cincinnati | Conditions: Degenerative Intervertebral Discs, Sciatic Radiculopathy | Phase 4 | Status: WITHDRAWN